The China National Medical Products Administration (NMPA) has granted expanded approval to MSD's GARDASIL, [Human ...
Human Papillomavirus (HPV) is a widespread sexually transmitted infection, affecting nearly 80 percent of sexually active ...
HPV-16 E7 is under clinical development by Gilead Sciences and currently in Phase II for Oropharyngeal Cancer.
The recipient in Changsha, the capital of Hunan province, became the first man on the Chinese mainland to receive the HPV ...
China NMPA grants expanded approval for Merck’s Gardasil for use in males 9-26 years of age to help prevent certain HPV-related cancers & diseases: Rahway, New Jersey Friday, Ja ...
The HPV vaccine, Gardasil, has gained approval for additional indications from China's National Medical Products ...